Clinical trial
A Randomized, Double-blind, Crossover Study to Investigate the Bronchodilatation Post-inhalation of GSK961081 Alone and With the Addition of Cumulative Doses of Short Acting Bronchodilators (Salbutamol and Ipratropium Bromide) in Patients With COPD
NCT00674817 is registered in ClinicalTrials.gov with Theravance Biopharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Crossover Study to Investigate the Bronchodilatation Post-inhalation of GSK961081 Alone and With the Addition of Cumulative Doses of Short Acting Bronchodilators (Salbutamol and Ipratropium Bromide) in Patients With COPD
- Lead sponsor
- Theravance Biopharma
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 1, 2008
- Completion date
- October 19, 2008
- Enrollment
- 45 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.